CP
Changzhou Pharmaceutical Factory (CPF)
Manufacturer · Changzhou, China
GMP
Overview
Changzhou Pharmaceutical Factory was established in 1949 and mainly makes cardiovascular APIs and finished tablets. Its company history lists repeated US FDA audits, EU GMP inspections and PMDA approvals for its Changzhou site and Nantong Chanyoo subsidiary. CPF holds active US Type II DMFs for semaglutide and tirzepatide.
Capabilities
- Peptide APIs
- Cardiovascular APIs
- Finished formulations
- Export to regulated markets
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |